CEDARS SINAI INTELLECTUAL PROPERTY… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

JAMES D LAUR

Phone

3104233277

Tax Period

2023-07-01 to 2024-06-30

CEDARS SINAI INTELLECTUAL PROPERTY COMPANY, founded in 2021, is a mid-sized nonprofit in the Medical Research sector that reported $12.3M in total revenue in fiscal year 2023. Revenue fell 99% from the prior year — a significant decline worth monitoring. Net assets of $143.3M represent 140 months of operating reserves.

Mission

CEDARS SINAI INTELLECTUAL PROPERTY COMPANY ("CSIP") IS ORGANIZED AND OPERATED EXCLUSIVELY FOR CHARITABLE PURPOSES. CSIP'S SPECIFIC PURPOSE IS TO SUPPORT AND BENEFIT CEDARS-SINAI MEDICAL CENTER ("CSMC") THROUGH(SEE SCHEDULE O FOR CONTINUATION)(CONTINUED)THE MANAGEMENT AND LICENSING OF INTELLECTUAL PROPERTY ASSETS DERIVED FROM CSMC'S RESEARCH ACTIVITIES INCLUDING DEVELOPMENT OF EARLY-STAGE COMPANIES THAT LICENSE AND DEVELOP CSMC INTELLECTUAL PROPERTY.

Program Service Accomplishments

Program 1

Expenses: $11,969,617 Revenue: $0

CSIP IS ORGANIZED AND OPERATED EXCLUSIVELY FOR CHARITABLE PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. CSIP'S PROGRAM SERVICES INCLUDE THE FOLLOWING ACTIVITIES:1)...

CSIP IS ORGANIZED AND OPERATED EXCLUSIVELY FOR CHARITABLE PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. CSIP'S PROGRAM SERVICES INCLUDE THE FOLLOWING ACTIVITIES:1) EDUCATE THE FACULTY AND RESEARCH STAFF AT CSMC ABOUT THE BASIC PRINCIPLES OF INTELLECTUAL PROPERTY PROTECTION;2) CAPTURE NEW TECHNOLOGIES AND DISCOVERIES MADE AT CSMC, AND SECURE THE APPROPRIATE INTELLECTUAL PROPERTY PROTECTION FOR THE TECHNOLOGIES AND DISCOVERIES;(CONTINUED ON SCHEDULE O)(CONTINUED)3) EVALUATE THE POTENTIAL OF THE TECHNOLOGIES AND DISCOVERIES FOR FURTHER DEVELOPMENT INTO PRODUCTS AND SERVICES THAT COULD HAVE A POSITIVE IMPACT ON ILLNESS OR DISEASE, UNMET HEALTH NEEDS, OR HEALTH CARE DELIVERY;4) SUPPORT FURTHER DEVELOPMENT OF THE TECHNOLOGY TO CREATE THE POTENTIAL FOR IT TO BECOME A PRODUCT OR SERVICE BENEFITING THE COMMUNITY AS A WHOLE; 5) DEVELOP AND MAINTAIN A NETWORK OF RESEARCHERS AND TECHNOLOGY PROFESSIONALS IN ACADEMIC INSTITUTIONS AND INDUSTRY THAT CAN COLLABORATE TO SUPPORT EARLY-STAGE DISCOVERIES MADE THROUGH CSMC BIOMEDICAL RESEARCH; 6) IDENTIFY COMMERCIAL PARTNERS TO LICENSE THE INTELLECTUAL PROPERTY OR SUPPORT THE DEVELOPMENT OF THE TECHNOLOGY BY NEW COMPANIES CREATED FOR THAT PURPOSE;7) ADVISE AND INVEST IN EARLY-STAGE COMPANIES THAT LICENSE THE INTELLECTUAL PROPERTY OR PARTNER WITH CSMC TO DEVELOP THE TECHNOLOGY; AND,8) MANAGE THE RELATIONSHIPS WITH LICENSEES, AND COMPANIES IN CSIP'S INVESTMENT PORTFOLIO.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $-2,105,235

Other Revenue $14,363,845

TOTAL REVENUE $12,258,610

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $11,969,617

Other Expenses $12,317,801

TOTAL EXPENSES $12,317,801

Year-over-Year Comparison

	2023	2022	Change
Revenue	$12,258,610	$898,368,973	-1.0%
Expenses	$12,317,801	$9,050,545	+0.4%
Net Income	$-59,191	$889,318,428	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$5,469,530

Total Directors

$10,676,071

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SHLOMO MELMED	DIRECTOR	1.00	Director	$0	$602,262	$4,249,450
EDWARD M PRUNCHUNAS	DIRECTOR	1.00	Director	$0	$274,507	$1,698,851
DAVID M WRIGLEY	TREASURER AND DIRECTOR	1.00	Officer Director	$0	$339,896	$3,198,667
JAMES D LAUR	PRESIDENT AND DIRECTOR	17.00	Officer Director	$0	$195,233	$1,529,103
PAMELA COLLINGWOOD	SECRETARY	45.00	Officer	$0	$67,641	$474,447
ERIC SEE	SECRETARY	26.00	Officer	$0	$32,246	$267,313

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$12,258,610	$12,317,801	$149,685,069	$-59,191
2023	$898,368,973	$9,050,545	$122,775,513	$889,318,428
2022	$16,082,219	$276	$136,009,425	$16,081,943
2021	No data	No data	$115,042,100	No data

CEDARS SINAI INTELLECTUAL PROPERTY COMPANY